CERo Property Plant And Equipment Net vs Non Current Assets Total Analysis

CEROW Stock   0.01  0.0006  7.14%   
CERo Therapeutics financial indicator trend analysis is way more than just evaluating CERo Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CERo Therapeutics is a good investment. Please check the relationship between CERo Therapeutics Property Plant And Equipment Net and its Non Current Assets Total accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CERo Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Property Plant And Equipment Net vs Non Current Assets Total

JavaScript chart by amCharts 3.21.152014201620182020202220243.6M3.7M3.8M3.9M4M4.1M4.2M4.3M4.4M4.5M4.6M 10M20M40M60M80M100M120M140M160M
JavaScript chart by amCharts 3.21.15Property Plant And Equipment Nettotal: 53.6MNon Current Assets Totaltotal: 1.6B

Property Plant And Equipment Net vs Non Current Assets Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CERo Therapeutics Property Plant And Equipment Net account and Non Current Assets Total. At this time, the significance of the direction appears to have almost identical trend.
Property Plant And Equipment NetNon Current Assets TotalDiversified AwayProperty Plant And Equipment NetNon Current Assets TotalDiversified Away100%
The correlation between CERo Therapeutics' Property Plant And Equipment Net and Non Current Assets Total is 0.92. Overlapping area represents the amount of variation of Property Plant And Equipment Net that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of CERo Therapeutics Holdings, assuming nothing else is changed. The correlation between historical values of CERo Therapeutics' Property Plant And Equipment Net and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant And Equipment Net of CERo Therapeutics Holdings are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Property Plant And Equipment Net i.e., CERo Therapeutics' Property Plant And Equipment Net and Non Current Assets Total go up and down completely randomly.

Correlation Coefficient

0.92
Relationship DirectionPositive 
Relationship StrengthVery Strong

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Most indicators from CERo Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CERo Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CERo Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Selling General Administrative is likely to drop to 2,748 in 2024. Enterprise Value Over EBITDA is likely to drop to -31.51 in 2024
 2010 2022 2023 2024 (projected)
Interest Income986.7K142.1K127.9K121.5K
Net Interest Income986.7K142.1K127.9K121.5K

CERo Therapeutics fundamental ratios Correlations

0.95-0.44-0.621.00.95-0.980.470.97-0.89-0.410.990.80.98-0.410.98-0.790.99-0.850.53-0.880.96-0.87-0.63-0.850.97
0.95-0.69-0.830.970.83-0.990.710.86-0.7-0.670.980.610.99-0.670.98-0.60.91-0.640.24-0.981.0-0.7-0.84-0.660.98
-0.44-0.690.98-0.49-0.180.61-1.0-0.22-0.031.0-0.530.1-0.591.0-0.57-0.1-0.34-0.110.540.81-0.65-0.010.97-0.06-0.58
-0.62-0.830.98-0.67-0.390.77-0.98-0.430.190.97-0.71-0.11-0.750.97-0.740.11-0.540.110.340.91-0.80.211.00.16-0.74
1.00.97-0.49-0.670.94-0.990.520.96-0.86-0.461.00.770.99-0.460.99-0.760.99-0.810.47-0.910.98-0.84-0.68-0.820.98
0.950.83-0.18-0.390.94-0.880.210.99-0.97-0.150.920.940.89-0.150.88-0.830.98-0.950.72-0.730.87-0.91-0.4-0.90.85
-0.98-0.990.610.77-0.99-0.88-0.63-0.910.780.58-1.0-0.68-1.00.58-0.990.68-0.950.72-0.350.96-1.00.770.770.74-0.99
0.470.71-1.0-0.980.520.21-0.630.250.0-1.00.56-0.070.62-1.00.60.070.370.08-0.51-0.820.67-0.02-0.980.030.61
0.970.86-0.22-0.430.960.99-0.910.25-0.97-0.190.940.910.91-0.190.92-0.860.99-0.950.71-0.750.88-0.93-0.44-0.920.89
-0.89-0.7-0.030.19-0.86-0.970.780.0-0.97-0.06-0.83-0.95-0.79-0.06-0.80.92-0.931.0-0.860.57-0.740.970.20.97-0.77
-0.41-0.671.00.97-0.46-0.150.58-1.0-0.19-0.06-0.50.13-0.571.0-0.54-0.13-0.31-0.140.560.79-0.63-0.040.96-0.09-0.56
0.990.98-0.53-0.711.00.92-1.00.560.94-0.83-0.50.741.0-0.50.99-0.730.98-0.780.43-0.930.99-0.82-0.71-0.790.98
0.80.610.1-0.110.770.94-0.68-0.070.91-0.950.130.740.690.130.68-0.760.86-0.950.84-0.50.67-0.84-0.12-0.840.63
0.980.99-0.59-0.750.990.89-1.00.620.91-0.79-0.571.00.69-0.571.0-0.70.96-0.740.36-0.950.99-0.78-0.76-0.750.99
-0.41-0.671.00.97-0.46-0.150.58-1.0-0.19-0.061.0-0.50.13-0.57-0.54-0.13-0.31-0.140.560.79-0.63-0.040.96-0.09-0.56
0.980.98-0.57-0.740.990.88-0.990.60.92-0.8-0.540.990.681.0-0.54-0.740.96-0.750.39-0.930.98-0.81-0.74-0.781.0
-0.79-0.6-0.10.11-0.76-0.830.680.07-0.860.92-0.13-0.73-0.76-0.7-0.13-0.74-0.830.92-0.840.44-0.610.990.120.99-0.74
0.990.91-0.34-0.540.990.98-0.950.370.99-0.93-0.310.980.860.96-0.310.96-0.83-0.90.61-0.830.93-0.9-0.55-0.890.94
-0.85-0.64-0.110.11-0.81-0.950.720.08-0.951.0-0.14-0.78-0.95-0.74-0.14-0.750.92-0.9-0.90.5-0.680.960.120.97-0.72
0.530.240.540.340.470.72-0.35-0.510.71-0.860.560.430.840.360.560.39-0.840.61-0.9-0.070.29-0.830.33-0.860.36
-0.88-0.980.810.91-0.91-0.730.96-0.82-0.750.570.79-0.93-0.5-0.950.79-0.930.44-0.830.5-0.07-0.970.550.920.51-0.92
0.961.0-0.65-0.80.980.87-1.00.670.88-0.74-0.630.990.670.99-0.630.98-0.610.93-0.680.29-0.97-0.71-0.81-0.680.97
-0.87-0.7-0.010.21-0.84-0.910.77-0.02-0.930.97-0.04-0.82-0.84-0.78-0.04-0.810.99-0.90.96-0.830.55-0.710.221.0-0.81
-0.63-0.840.971.0-0.68-0.40.77-0.98-0.440.20.96-0.71-0.12-0.760.96-0.740.12-0.550.120.330.92-0.810.220.17-0.75
-0.85-0.66-0.060.16-0.82-0.90.740.03-0.920.97-0.09-0.79-0.84-0.75-0.09-0.780.99-0.890.97-0.860.51-0.681.00.17-0.77
0.970.98-0.58-0.740.980.85-0.990.610.89-0.77-0.560.980.630.99-0.561.0-0.740.94-0.720.36-0.920.97-0.81-0.75-0.77
Click cells to compare fundamentals

CERo Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CERo Stock Analysis

When running CERo Therapeutics' price analysis, check to measure CERo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CERo Therapeutics is operating at the current time. Most of CERo Therapeutics' value examination focuses on studying past and present price action to predict the probability of CERo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CERo Therapeutics' price. Additionally, you may evaluate how the addition of CERo Therapeutics to your portfolios can decrease your overall portfolio volatility.